Novel Approaches for the Treatment of Antimicrobial-Resistant Pathogens
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Novel Antimicrobial Agents".
Deadline for manuscript submissions: 31 July 2025 | Viewed by 37529
Special Issue Editor
Interests: zoonotic pathogens; drug discovery; antimicrobial resistance; gene expression during infection; control of foodborne bacterial pathogens; host responses (immunity) to infectious diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Antimicrobial resistance is a significant problem in humans and animals worldwide. The extensive and non-selective use of antibiotics has resulted in the rise of bacteria that are resistant to antimicrobial agents, hence limiting the available treatment options for multidrug-resistant bacterial infections. To control antimicrobial resistance (AMR), it is imperative to engage in the systematic surveillance of AMR infection dissemination. Furthermore, there is an urgent need to identify and develop novel strategies that can control antimicrobial-resistant pathogens. These approaches include, but are not limited to, probiotics, prebiotics, antivirulence and quorum sensing inhibitors, small molecules, peptides, essential oils, nanoparticles and vaccines. This Special Issue welcomes high-quality original research papers on topics related to antibiotic alternatives.
Dr. Yosra A. Helmy
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance diagnosis and surveillance
- antibiotic alternatives and development of novel drugs
- whole-genome sequencing
- gut microbiota
- infectious pathogens in animals and humans
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
